Treatment Intensification With Either Fludarabine, AraC, G-CSF and Idarubicin, or Cladribine Plus Daunorubicin and AraC on the Basis of Residual Disease Status in Older Patients With AML: Results From the NCRI AML18 Trial

In this study of older patients with AML considered fit and with evidence of residual disease after first induction, chemotherapy intensification improved survival. DAC intensification was better tolerated than FLAG-Ida.

Authors

Institutions

Publication Details

Journal
Journal of Clinical Oncology
Published
2025-02-20
DOI
https://doi.org/10.1200/jco.24.00259
Citations
9
Primary Topic
Acute Myeloid Leukemia Research
Type
article
Field-Weighted Citation Impact
15.93

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Treatment Intensification With Either Fludarabine, AraC, G-CSF and Idarubicin, or Cladribine Plus Daunorubicin and AraC on the Basis of Residual Disease Status in Older Patients With AML: Results From the NCRI AML18 Trial

Steven Knapper, Richard Kelly, Marlen Metzner, Nuria Marquez Almuina et al.
9 citations
Journal of Clinical Oncology
Acute Myeloid Leukemia Research
15.93
article

Treatment Intensification With Either Fludarabine, AraC, G-CSF and Idarubicin, or Cladribine Plus Daunorubicin and AraC on the Basis of Residual Disease Status in Older Patients With AML: Results From the NCRI AML18 Trial

Steven Knapper, Richard Kelly, Marlen Metzner, Nuria Marquez Almuina, Abin Thomas, Amanda Gilkes, Sylvie Freeman, Lucy Marsh, Rob S. Sellar, Nigel H. Russell, Robert K. Hills, Mike Dennis, Priyanka Mehta, Georgia Andrew, Paul Cahalin, Ian Thomas, Ulrik Malthe Overgaard, Jenny Byrne, Paresh Vyas, Nicholas McCarthy, Sarah S. Burns
article en
9 citations

Abstract

In this study of older patients with AML considered fit and with evidence of residual disease after first induction, chemotherapy intensification improved survival. DAC intensification was better tolerated than FLAG-Ida.

Journal of Clinical OncologyVol. 43(6)
University College Hospital (GB), North Bristol NHS Trust (GB), Nottingham University Hospitals NHS Trust (GB), Guy's and St Thomas' NHS Foundation Trust (GB), University Hospitals Bristol NHS Foundation Trust (GB), St James's University Hospital (GB), Rigshospitalet (DK), University College Birmingham (GB), University of Oxford (GB), National Heart, Lung, and Blood Institute (US), MRC Weatherall Institute of Molecular Medicine (GB), Blackpool Teaching Hospitals NHS Foundation Trust (GB), The Christie NHS Foundation Trust (GB), CRUK Lung Cancer Centre of Excellence (GB), University College London (GB), Cardiff University (GB)
National Cancer Research Institute, Cancer Research UK
Openalex Percentile: Top 1%
Acute Myeloid Leukemia Research
15.93
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.